Assetmark »

Immunovant shares owned by Assetmark

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Assetmark

Quarter filed Position value Share count Share price at filing
2024-12-31 $65k 2.6k 24.77
2024-09-30 $82k 2.9k 28.51
2024-06-30 $44k 1.7k 26.40
2024-03-31 $53k 1.6k 32.31
2023-12-31 $61k 1.5k 42.13

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
NVIDIA Corporation (NVDA)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Ser Tr Bloomberg High Y (JNK)

View all positions for Assetmark

Top funds holding Immunovant

FMR
Vanguard Group
Armistice Capital
BlackRock
Deep Track Capital
T. Rowe Price Investment Management
State Street Corporation
Alpine Partners VI
Perceptive Advisors
Baker Bros. Advisors
Geode Capital Management
Two Seas Capital
Viking Global Investors
Paradigm Biocapital Advisors
Pictet Asset Management Holding SA

View all funds holding Immunovant